Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · SPDR (State Street)

XPH Holdings: What State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF Owns

Ticker XPH · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
+2.8%annualized
1-yr return
+31.6%as of Dec 2025
Net assets
$428.4Mall share classes
Holdings
67

Bottom line

What does XPH hold?

XPH held 67 positions as of Jun 30, 2026. Its largest holding is State Street Global Advisors at 8.58% of the fund, and the top 10 positions add up to 28.9%. By asset type it is 100% stocks, 9% cash & short-term funds.

Updated Aug 28, 2026

XPH top 25 holdings

#HoldingType% of fundValue
1 State Street Global Advisors
State Street Navigator Securities Lending Portfolio II
Cash & short-term funds 8.58%$36.8M
2 Definium Therapeutics Inc Stocks 3.09%$13.2M
3 MBX Biosciences Inc Stocks 2.72%$11.6M
4 Alumis Inc Stocks 2.14%$9.2M
5 AtaiBeckley Inc Stocks 2.13%$9.1M
6 Trevi Therapeutics Inc Stocks 2.12%$9.1M
7 Enliven Therapeutics Inc Stocks 2.09%$9.0M
8 Amylyx Pharmaceuticals Inc Stocks 2.04%$8.7M
9 VeraDermics Inc Stocks 2.02%$8.6M
10 Ligand Pharmaceuticals Inc Stocks 1.94%$8.3M
11 Nuvation Bio Inc Stocks 1.89%$8.1M
12 Edgewise Therapeutics Inc Stocks 1.88%$8.1M
13 Nektar Therapeutics Stocks 1.88%$8.0M
14 Liquidia Corp Stocks 1.86%$8.0M
15 Maze Therapeutics Inc Stocks 1.85%$7.9M
16 Harrow Inc Stocks 1.81%$7.7M
17 EyePoint Inc Stocks 1.77%$7.6M
18 Amneal Pharmaceuticals Inc Stocks 1.72%$7.4M
19 Ocular Therapeutix Inc Stocks 1.71%$7.3M
20 Corcept Therapeutics Inc Stocks 1.70%$7.3M
21 Crinetics Pharmaceuticals Inc Stocks 1.66%$7.1M
22 Pacira BioSciences Inc Stocks 1.65%$7.1M
23 Merck & Co Inc Stocks 1.65%$7.1M
24 Indivior Pharmaceuticals Inc Stocks 1.64%$7.0M
25 Elanco Animal Health Inc Stocks 1.64%$7.0M

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026

Asset mix

Stocks100.0%
Cash & short-term funds8.6%

Country exposure

CA3.1%
GB1.6%
IE3.0%
KY1.0%
SG1.6%
US98.4%